I can just tell you how it impacted our company, because we work contract research to keep our company going. When we started, we charged, say, $100,000 U.S. to Pfizer for a project. Back then, our Canadian dollar was at 62ยข, so it actually worked out to be about $138,000 or $140,000. We continue to do contract research, and we still charge in U.S. dollars internationally, but we're trying to decide whether that is the best way to go anymore.
Also, in regard to cost, which is important, people have to realize that when we started out.... Because of my background in economic development, I knew how regions would provide incentives to Phenomenone in other countries. We were recruited to locate in the States, but you would be paying a research scientist in Boston the equivalent of about $130,000 or $140,000 Canadian, whereas in Canada we'd pay $50,000 to $60,000, roughly, or maybe $70,000, for that same scientist.
The salaries are getting closer. All our costs are getting to the point that you would wonder.... The capital is in San Francisco, Boston, and New York, and every time you go out to meet investors, they ask why we don't locate in San Francisco. They say they would be more interested in investing in us if we were there. We used to have a major cost advantage, but now we don't.